Show simple item record

dc.contributor.authorBadran, Abdulen
dc.contributor.authorHollocks, Matthew Jen
dc.contributor.authorBrookes, Rebecca Len
dc.contributor.authorMorris, Robin Gen
dc.contributor.authorMarkus, Hughen
dc.date.accessioned2019-08-08T13:51:29Z
dc.date.available2019-08-08T13:51:29Z
dc.date.issued2019-07en
dc.identifier.issn1382-5585
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/295468
dc.description.abstract"Normal" age-related cognitive decline has been associated with cardiovascular risk factors. Framingham Vascular Age is age-normed cardiovascular risk which may help communicate risk to patients and identify those at relatively higher risk. We aim to assess the association between Framingham Vascular Age and cognition. 346 "healthy" participants (57±10 years) without neuropsychiatric disorders or clinical manifestations of cardiovascular disease were studied. Cognition was evaluated using the Brief Memory and Executive Test and Framingham Vascular Age was calculated. The association between Framingham Vascular Age and cognitive performance was determined through General Linear Models to control for covariates. Framingham Vascular age was associated with poorer Memory and Executive Function/Processing Speed indices (p= 0.019 and p<0.001, respectively). We conclude Framingham Vascular Age is associated with worse Executive Function/Processing Speed and Memory. Vascular Age may help identify patients at higher risk of age-related cognitive decline with implications for communicating the morbidity associated with cardiovascular risk.
dc.description.sponsorshipThis work was supported by the Stroke Association under Grant TSA 2010/08; British Heart Foundation under Grant PG/13/30/30005; and Stroke Association/British Heart Foundation Programme under Grant TSA BHF 2010/01. Hugh Markus is supported by a National Institute for Health Research Senior Investigator award and his work is supported by the Cambridge University Hospitals Trust National Institute for Health Research Comprehensive Biomedical Research Centre.
dc.languageengen
dc.language.isoenen
dc.publisherTaylor & Francis
dc.subjectAge-related cognitive declineen
dc.subjectFraminghamen
dc.subjectbrief memory and executive testen
dc.subjectscreeningen
dc.subjectvascular ageen
dc.titleFramingham vascular age is associated with worse cognitive performance in the middle-aged and elderly.en
dc.typeArticle
prism.endingPage540
prism.issueIdentifier4en
prism.publicationDate2019en
prism.publicationNameNeuropsychol Dev Cogn B Aging Neuropsychol Cognen
prism.startingPage531
prism.volume26en
dc.identifier.doi10.17863/CAM.42524
dcterms.dateAccepted2018-07-06en
rioxxterms.versionofrecord10.1080/13825585.2018.1499866en
rioxxterms.versionAMen
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-07en
dc.contributor.orcidMarkus, Hugh [0000-0002-9794-5996]
dc.identifier.eissn1744-4128
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idStroke Association (TSA 2010/08)
pubs.funder-project-idBritish Heart Foundation (PG/13/30/30005)
cam.issuedOnline2018-07-27en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record